About this trial
Hystrectomy is a surgical procedure that involves removal of uterus from the body of patient using a lower abdominal incision. This is an extremely painful procedure which causes discomfort and greatly increases opioids consumption in the peri-operative period. This can be reduced by using nerve blocks such as Erector spinae plane block.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
American Society of Anesthesiologists (ASA) class: I, II and III .
Elective Hysterectomy under General Anesthesia.
Disqualifiers
Lack of consent
Body mass index >35 kg/m2
Allergic to study medicine
Opioid abuse or misuse disorder
Trial design
Parallel
Treatments tested in this trial
Erector Spinae (ESP) Block with Bupivacaine (Marcaine®)
DrugBilateral Erector Spinae Block at T10 level using 30ml of 0.25% Bupivacaine will be administered under Ultrasound guidance before surgical incision.
Placebo
DrugBilateral Erector Spinae Block at T10 level using 30ml of Normal saline will be administered under Ultrasound guidance before surgical incision.
Treatment groups
Trial outcomes
Primary outcomes
Total Intra-operative Fentanyl consumption
Secondary outcomes
Total amount of IV Tramadol consumed in post operative period
Post operative pain score
This will be assessed Visual Analog Scale
Sponsors and contacts
Click on the lead sponsor to view all of their trials.